Your browser doesn't support javascript.
loading
The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism.
Ye, Shuangyan; Xu, Pengfei; Huang, Mengqiu; Chen, Xi; Zeng, Sisi; Wang, Qianli; Chen, Jianping; Li, Keyi; Gao, Wenwen; Liu, Ruiyuan; Liu, Jingxian; Shao, Yihao; Zhang, Hui; Xu, Yang; Zhang, Qianbing; Zhong, Zhuo; Wei, Zibo; Wang, Jiale; Hao, Bingtao; Huang, Wenhua; Liu, Qiuzhen.
Afiliación
  • Ye S; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Xu P; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Huang M; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Chen X; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Zeng S; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Wang Q; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Chen J; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Li K; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Gao W; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Liu R; School of Biomedical Engineering, Southern Medical University, Guangzhou, China.
  • Liu J; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Shao Y; The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Zhang H; Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
  • Xu Y; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Zhang Q; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Zhong Z; Guangzhou Hospital of integrated Traditional and West Medicine, Guangzhou, China.
  • Wei Z; Center for medical transformation, Shunde Hospital, Southern Medical University, Foshan, China.
  • Wang J; Center for medical transformation, Shunde Hospital, Southern Medical University, Foshan, China.
  • Hao B; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China. haobt123@smu.edu.cn.
  • Huang W; National Key Discipline of Human Anatomy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China. huangwenhua2009@139.com.
  • Liu Q; Department of Human Anatomy, School of Basic Medical Sciences, Guangdong Medical University, Guangzhou, China. huangwenhua2009@139.com.
Cell Death Dis ; 11(5): 312, 2020 05 04.
Article en En | MEDLINE | ID: mdl-32366855
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Óxidos N-Cíclicos / Glutamina / Compuestos Heterocíclicos / Neoplasias Límite: Animals / Female / Humans Idioma: En Revista: Cell Death Dis Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Óxidos N-Cíclicos / Glutamina / Compuestos Heterocíclicos / Neoplasias Límite: Animals / Female / Humans Idioma: En Revista: Cell Death Dis Año: 2020 Tipo del documento: Article País de afiliación: China